People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

Increasing aging populations and growing hospital infrastructures will drive demand for rheumatoid arthritis drugs.Wilmington ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As ...

In a recent study published in The New England ... in overweight arthritis patients. A once-weekly 2.4 mg subcutaneous injection of the novel antidiabetic wonder drug was observed to reduce ...

Filgotinib, the rheumatoid arthritis (RA) oral drug that never made it to the U.S. market but is sold across Europe, Great ...

By Hugo Francisco de Souza New research highlights the potential for weight-loss medication to ease arthritis symptoms, ...

Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.

Two "key" genes have been identified by scientists linking the painful condition and the bone disease osteoporosis.

People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research published Wednesday in the New England Journal of Medicine finds.

The European Alliance of Associations for Rheumatology, in partnership with the Pediatric Rheumatology European Society (PReS ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

The decline was offset by sales of its newer arthritis drugs Skyrizi, which soared by more than 50% to $3.21 billion, and Rinvoq, which logged a 45% gain to $1.61 billion. The company lifted ...